Loading...
XTSEJWEL
Market cap1.06bUSD
Dec 24, Last price  
36.46CAD
1D
-1.78%
1Q
3.67%
IPO
108.34%
Name

Jamieson Wellness Inc

Chart & Performance

D1W1MN
XTSE:JWEL chart
P/E
31.90
P/S
2.26
EPS
1.14
Div Yield, %
1.98%
Shrs. gr., 5y
1.53%
Rev. gr., 5y
16.16%
Revenues
676m
+23.53%
193,218,000230,865,000248,331,000300,619,000319,776,000344,980,000403,661,000451,032,000547,369,000676,172,000
Net income
48m
-9.33%
-33,176,000-95,382,000-25,166,000-23,787,00026,673,00031,657,00041,598,00052,082,00052,808,00047,882,000
CFO
32m
-37.31%
9,847,00018,009,00029,009,00017,845,00027,805,00016,396,00040,596,00044,405,00050,589,00031,713,000
Dividend
Aug 30, 20240.21 CAD/sh
Earnings
Mar 11, 2025

Profile

Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells natural health products in Canada and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and Lorna Vanderhaeghe brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands. The Strategic Partners segment provides manufacturing and product development services on a contract manufacturing basis to blue-chip consumer health companies and retailers. Jamieson Wellness Inc. sells its products to distributors, and retail and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.
URL
https://investors.jamiesonwellness.com
IPO date
Jul 07, 2017
Employees
891
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
676,172
23.53%
547,369
21.36%
451,032
11.74%
Cost of revenue
588,785
464,180
375,002
Unusual Expense (Income)
NOPBT
87,387
83,189
76,030
NOPBT Margin
12.92%
15.20%
16.86%
Operating Taxes
19,631
17,695
18,383
Tax Rate
22.46%
21.27%
24.18%
NOPAT
67,756
65,494
57,647
Net income
47,882
-9.33%
52,808
1.39%
52,082
25.20%
Dividends
(30,257)
(26,323)
(22,107)
Dividend yield
2.24%
1.78%
1.32%
Proceeds from repurchase of equity
(29,004)
BB yield
2.14%
Debt
Debt current
7,546
4,852
2,876
Long-term debt
496,471
461,931
169,997
Deferred revenue
3,544
Other long-term liabilities
1,078
62,860
20,872
Net debt
467,154
(311,287)
(246,530)
Cash flow
Cash from operating activities
31,713
50,589
44,405
CAPEX
(8,835)
(14,570)
(22,284)
Cash from investing activities
(35,131)
(256,530)
(22,284)
Cash from financing activities
14,041
225,406
(16,512)
FCF
28,296
24,175
9,932
Balance
Cash
36,863
26,240
6,775
Long term investments
751,830
412,628
Excess cash
3,054
750,702
396,851
Stockholders' equity
447,401
414,476
327,235
Invested Capital
942,205
477,440
188,307
ROIC
9.55%
19.68%
30.97%
ROCE
8.69%
8.76%
13.37%
EV
Common stock shares outstanding
42,651
42,116
41,681
Price
31.73
-9.58%
35.09
-12.58%
40.14
11.10%
Market cap
1,353,300
-8.43%
1,477,863
-11.67%
1,673,073
12.50%
EV
1,862,716
1,166,576
1,426,543
EBITDA
107,710
100,437
90,304
EV/EBITDA
17.29
11.61
15.80
Interest
22,784
12,417
5,657
Interest/NOPBT
26.07%
14.93%
7.44%